SETH MCMILLIN-ROBB: Open Payments
NPI 1669786273 · CLIVE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,117 in 122 payments from 21 companies in 2025. Trend: 2023 $1,689 · 2024 $1,498 · 2025 $2,117
Food & beverage: $2,117
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $290 |
| ABBVIE INC. | 17 | $261 |
| Janssen Biotech, Inc. | 11 | $205 |
| E.R. Squibb & Sons, L.L.C. | 16 | $192 |
| Novartis Pharmaceuticals Corporation | 12 | $161 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $158 |
| Lilly USA, LLC | 7 | $158 |
| Amgen Inc. | 9 | $148 |
| Organon LLC | 5 | $72 |
| Arcutis Biotherapeutics, Inc. | 4 | $69 |
Products named: Bimzelx, TREMFYA, SKYRIZI, Sotyktu, ILUMYA, Otezla, TALTZ, COSENTYX.
Industry payments across IA — which companies pay providers there.
